{"id":"NCT00397033","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","briefTitle":"Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.","officialTitle":"A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Two Dosages of Paliperidone ER in the Treatment of Patients With Schizoaffective Disorder.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-11","primaryCompletion":"2008-02","completion":"2008-02","firstPosted":"2006-11-08","resultsPosted":"2009-07-28","lastUpdate":"2013-07-29"},"enrollment":316,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Schizoaffective Disorder","Psychotic Disorder"],"interventions":[{"type":"DRUG","name":"Paliperidone ER","otherNames":[]},{"type":"DRUG","name":"Paliperidone ER","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"002","type":"EXPERIMENTAL"},{"label":"001","type":"EXPERIMENTAL"},{"label":"003","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to measure the effectiveness and assess the safety of two dosages of the antipsychotic paliperidone extended-release (ER) in patients who are experiencing an acute episode of schizoaffective disorder.","primaryOutcome":{"measure":"Baseline Positive and Negative Symptoms of Schizophrenia (PANSS) Total Score","timeFrame":"Baseline","effectByArm":[{"arm":"Placebo","deltaMin":91.6,"sd":12.5},{"arm":"Paliperidone Extended Release (ER) Low Dose","deltaMin":95.9,"sd":13},{"arm":"Paliperidone Extended Release (ER) High Dose","deltaMin":92.7,"sd":12.6}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":6},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["26934062","20492853"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_JNJ_6051&studyid=33&filename=CR010498_CSR.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":107},"commonTop":["Headache","Tremor","Nausea","Insomnia","Akathisia"]}}